Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Gsk Plc ADR (GSK)

Gsk Plc ADR (GSK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 72,262,592
  • Shares Outstanding, K 2,047,099
  • Annual Sales, $ 46,910 M
  • Annual Income, $ 6,030 M
  • 60-Month Beta 0.66
  • Price/Sales 1.51
  • Price/Cash Flow 9.77
  • Price/Book 7.00
Trade GSK with:

Options Overview Details

View History
  • Implied Volatility 27.61% ( +1.19%)
  • Historical Volatility 14.51%
  • IV Percentile 66%
  • IV Rank 42.01%
  • IV High 41.76% on 09/26/22
  • IV Low 17.37% on 03/28/22
  • Put/Call Vol Ratio 0.57
  • Today's Volume 3,732
  • Volume Avg (30-Day) 6,841
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 177,622
  • Open Int (30-Day) 239,853

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.59
  • Number of Estimates 3
  • High Estimate 0.67
  • Low Estimate 0.52
  • Prior Year 0.86
  • Growth Rate Est. (year over year) -31.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.23 +3.13%
on 01/06/23
35.73 -1.20%
on 01/19/23
+0.23 (+0.66%)
since 12/27/22
3-Month
31.22 +13.07%
on 11/11/22
39.74 -11.17%
on 12/06/22
+2.58 (+7.89%)
since 10/27/22
52-Week
28.47 +24.01%
on 09/26/22
46.97 -24.85%
on 04/11/22
-10.44 (-22.82%)
since 01/27/22

Most Recent Stories

More News
FDA Pulls EUA Granted to AstraZeneca's (AZN) Evusheld

AstraZeneca's (AZN) Evusheld is no longer authorized for use in the United States after laboratory data showed that it does not neutralize Omicron subvariants.

AZN : 65.53 (-0.70%)
GSK : 35.30 (-0.11%)
LLY : 342.10 (-1.70%)
VIR : 30.85 (+2.87%)
Earnings Preview: Bristol Myers Squibb (BMY) Q4 Earnings Expected to Decline

Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BMY : 72.45 (-0.74%)
GSK : 35.30 (-0.11%)
How Could GSK's RSV Vaccine Change its Valuation?

GSK's RSV vaccine could be a good earner for the company, according to outside analysts and its own predictions for the future.

GSK : 35.30 (-0.11%)
PFE : 43.79 (-1.04%)
MRNA : 189.35 (-2.01%)
GSK (GSK) Gains As Market Dips: What You Should Know

GSK (GSK) closed the most recent trading day at $35.17, moving +1.35% from the previous trading session.

GSK : 35.30 (-0.11%)
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GSK : 35.30 (-0.11%)
AMGN : 253.65 (-0.48%)
3 Penny Stocks That Could Make You Filthy Rich

These low-priced equities could deliver enormous returns for risk-tolerant shareholders.

GSK : 35.30 (-0.11%)
PGEN : 1.6400 (+1.23%)
RIGL : 1.8000 (-3.74%)
ME : 2.51 (+3.72%)
Gilead (GILD) Gains 21% in a Year: Will the Trend Continue?

Biotech giant Gilead (GILD) gains 21% in the past 12 months as its core HIV business maintains momentum despite volatility.

GSK : 35.30 (-0.11%)
GILD : 83.73 (+0.13%)
JNCE : 1.1900 (+5.31%)
COVID, Shmovid: This Could Be the Next Big Growth Story for Moderna Stock

Moderna could follow closely behind Pfizer and GSK in entering the lucrative RSV vaccine market.

MRNA : 189.35 (-2.01%)
PFE : 43.79 (-1.04%)
GSK : 35.30 (-0.11%)
GSK (GSK) Gains As Market Dips: What You Should Know

GSK (GSK) closed the most recent trading day at $35.61, moving +1.19% from the previous trading session.

GSK : 35.30 (-0.11%)
J&J (JNJ) Discontinues HIV Vaccine Phase III Mosaico Study

J&J (JNJ) discontinues phase III study on its investigational HIV vaccine regimen, which shows that the candidate lacks efficacy in preventing HIV.

SNY : 48.49 (-0.66%)
GSK : 35.30 (-0.11%)
JNJ : 168.23 (-0.39%)
PFE : 43.79 (-1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 35.77
2nd Resistance Point 35.60
1st Resistance Point 35.45
Last Price 35.30
1st Support Level 35.13
2nd Support Level 34.97
3rd Support Level 34.82

See More

52-Week High 46.97
Fibonacci 61.8% 39.90
Fibonacci 50% 37.72
Fibonacci 38.2% 35.53
Last Price 35.30
52-Week Low 28.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar